Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Minority Interest for 2 consecutive years, with $96.8 million as the latest value for Q2 2024.

  • On a quarterly basis, Minority Interest changed N/A to $96.8 million in Q2 2024 year-over-year; TTM through Jun 2024 was $96.8 million, a N/A change, with the full-year FY2023 number at $119.6 million, changed N/A from a year prior.
  • Minority Interest was $96.8 million for Q2 2024 at Artiva Biotherapeutics, down from $119.6 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $119.6 million in Q4 2023 to a low of $96.8 million in Q2 2024.